PMID: 39204186 Medical Disclaimer The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment
(2025) 11:e42738
Oral administration is supported by research showing BPC-157's gastric stability and absorption, making it viable for gastrointestinal conditions or patients uncomfortable with injections
Yes, we offer peptide therapy at our clinic
Before starting peptide therapy, a clinician should review: Current prescriptions and supplements Diabetes medications Personal and family thyroid history History of pancreatitis Gallbladder disease Kidney or liver problems Severe gastrointestinal symptoms Cancer history Hormonal or pituitary conditions Pregnancy plans Previous medication reactions Appetite-regulating medications can cause gastrointestinal side effects and may require additional caution in people with certain pancreatic, gallbladder, kidney, or thyroid histories
Overall, the present results build evidence supporting the role of oxytocin in AUD and its potential as a pharmacotherapeutic target [35], though the mechanism for this potential therapeutic effect is unknown